Currently, out of the existing stock ratings of Richard Newitter - 231 which are a Buy (64.35%), 128 which are a Hold (35.65%)

Richard Newitter

Work Performance Price Targets & Ratings Chart

Analyst Richard Newitter works at TRUIST and is covering the Healthcare sector with 671 price targets and ratings displayed on 29 stocks. Previously, Richard Newitter worked at LEERINK.

Richard Newitter's average stock forecast success ratio is 58.8% with an average time for price targets to be met of 178.41 days.

Most recent stock forecast was given on TMCI, Treace Medical Concepts at 10-Nov-2023.

Wall Street Analyst Richard Newitter

Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for TFX (TELEFLEX) at 1/31/2023. The price target of $260 was fulfilled within 2 days with a profit of $18.01 (7.44%) receiving and performance score of 37.21.

Average potential price target upside

of $43.35 (24.63%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $27.94 (15.76%) on BDX (BECTON, DICKINSON AND COMPANY).
of $27.9 (16.65%) on SYK (STRYKER).

ALC Alcon ALGN Align Technology AXGN AxoGen BDX Becton, Dickinson and Company GMED Globus Medical HOLX Hologic INSP Inspire Medical Systems ISRG Intuitive Surgical ITMR Itamar Medical Ltd LNTH Lantheus Holdings NUVA NuVasive SIEN Sientra SYK Stryker TFX Teleflex XENT ZBH Zimmer Biomet Holdings AXNX Axonics Modulation Technologies CNMD CONMED IART Integra LifeSciences Holdings MDT Medtronic plc WMGI EW Edwards Lifesciences NARI Inari Medical SPNE SeaSpine Holdings BSX Boston Scientific KIDS OrthoPediatrics NVRO Nevro PRCT TMCI Treace Medical Concepts

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Cecilia Furlong (MORGAN STANLEY)